Aozida

Health & BiotechSeries DGuangzhou, China

Latest round

Series D

Last raised

Nov 2026

Total raised

$15M

Investors

—

About Aozida

The medical device CRDMO platform will use the money to build an MAH mass-production plant, a provincial proof-of-concept and pilot facility, and to develop its medical device vertical AI model and agents.

Who invested in Aozida

No investors have been named on Aozida's rounds yet.

Funding rounds

  1. Series D

    Nov 13, 2026

    Amount

    $15M

    Investors

    Locked

Questions about Aozida

How much funding has Aozida raised?

Aozida has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Aozida last raise money?

Aozida's most recent round on record is a Series D, in Nov 2026.

What does Aozida do?

The medical device CRDMO platform will use the money to build an MAH mass-production plant, a provincial proof-of-concept and pilot facility, and to develop its medical device vertical AI model and agents.

Where is Aozida headquartered?

Aozida is headquartered in Guangzhou, China.

Which VCs invest in companies like Aozida?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back health & biotech companies at Aozida's stage. Their profiles are linked below.

Raising like Aozida? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.